190 related articles for article (PubMed ID: 27830374)
1. Prognostic role of expression of N-cadherin in patients with upper tract urothelial carcinoma: a multi-institutional study.
Abufaraj M; Moschini M; Soria F; Gust K; Özsoy M; Mathieu R; Rouprêt M; Margulis V; Karam JA; Wood CG; Briganti A; Bensalah K; Haitel A; Shariat SF
World J Urol; 2017 Jul; 35(7):1073-1080. PubMed ID: 27830374
[TBL] [Abstract][Full Text] [Related]
2. Prognostic role of decreased E-cadherin expression in patients with upper tract urothelial carcinoma: a multi-institutional study.
Favaretto RL; Bahadori A; Mathieu R; Haitel A; Grubmüller B; Margulis V; Karam JA; Rouprêt M; Seitz C; Karakiewicz PI; Cunha IW; Zequi SC; Wood CG; Weizer AZ; Raman JD; Remzi M; Rioux-Leclercq N; Jacquet-Kammerer S; Bensalah K; Lotan Y; Bachmann A; Rink M; Briganti A; Shariat SF
World J Urol; 2017 Jan; 35(1):113-120. PubMed ID: 27129576
[TBL] [Abstract][Full Text] [Related]
3. Increased nucleophosmin expression is a strong predictor of recurrence and prognosis in patients with N0M0 upper tract urothelial carcinoma undergoing radical nephroureterectomy.
Sawazaki H; Ito K; Asano T; Kuroda K; Sato A; Asakuma J; Horiguchi A; Seguchi K; Asano T
World J Urol; 2017 Jul; 35(7):1081-1088. PubMed ID: 27885451
[TBL] [Abstract][Full Text] [Related]
4. Expression profile of E-cadherin and N-cadherin in urothelial carcinoma of the upper urinary tract is associated with disease recurrence in patients undergoing nephroureterectomy.
Muramaki M; Miyake H; Terakawa T; Kusuda Y; Fujisawa M
Urology; 2011 Dec; 78(6):1443.e7-12. PubMed ID: 21924460
[TBL] [Abstract][Full Text] [Related]
5. Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
Cha EK; Shariat SF; Kormaksson M; Novara G; Chromecki TF; Scherr DS; Lotan Y; Raman JD; Kassouf W; Zigeuner R; Remzi M; Bensalah K; Weizer A; Kikuchi E; Bolenz C; Roscigno M; Koppie TM; Ng CK; Fritsche HM; Matsumoto K; Walton TJ; Ehdaie B; Tritschler S; Fajkovic H; Martínez-Salamanca JI; Pycha A; Langner C; Ficarra V; Patard JJ; Montorsi F; Wood CG; Karakiewicz PI; Margulis V
Eur Urol; 2012 Apr; 61(4):818-25. PubMed ID: 22284969
[TBL] [Abstract][Full Text] [Related]
6. Promising role of preoperative neutrophil-to-lymphocyte ratio in patients treated with radical nephroureterectomy.
Vartolomei MD; Mathieu R; Margulis V; Karam JA; Rouprêt M; Lucca I; Mbeutcha A; Seitz C; Karakiewicz PI; Fajkovic H; Wood CG; Weizer AZ; Raman JD; Rioux-Leclercq N; Haitel A; Bensalah K; Rink M; Briganti A; Xylinas E; Shariat SF
World J Urol; 2017 Jan; 35(1):121-130. PubMed ID: 27209168
[TBL] [Abstract][Full Text] [Related]
7. Prospective analysis of Ki-67 as an independent predictor of oncologic outcomes in patients with high grade upper tract urothelial carcinoma.
Krabbe LM; Bagrodia A; Lotan Y; Gayed BA; Darwish OM; Youssef RF; John G; Harrow B; Jacobs C; Gaitonde M; Sagalowsky AI; Shariat SF; Kapur P; Margulis V
J Urol; 2014 Jan; 191(1):28-34. PubMed ID: 23871758
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor messenger RNA-binding protein 3 expression helps prognostication in patients with upper tract urothelial carcinoma.
Lee DJ; Xylinas E; Rieken M; Khani F; Klatte T; Wood CG; Karam JA; Weizer AZ; Raman JD; Remzi M; Guo CC; Rioux-Leclercq N; Haitel A; Bolenz C; Bensalah K; Sagalowsky AI; Montorsi F; Lotan Y; Shariat SF; Robinson BD; Margulis V
Eur Urol; 2014 Aug; 66(2):379-85. PubMed ID: 24388440
[TBL] [Abstract][Full Text] [Related]
9. Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma.
Rink M; Robinson BD; Green DA; Cha EK; Hansen J; Comploj E; Margulis V; Raman JD; Ng CK; Remzi M; Bensalah K; Kabbani W; Haitel A; Rioux-Leclercq N; Guo CC; Chun FK; Kikuchi E; Kassouf W; Sircar K; Sun M; Sonpavde G; Lotan Y; Pycha A; Karakiewicz PI; Scherr DS; Shariat SF
J Urol; 2012 Aug; 188(2):398-404. PubMed ID: 22698626
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of Variant Histology in Upper Tract Urothelial Carcinoma Treated with Nephroureterectomy: A Systematic Review and Meta-Analysis.
Mori K; Janisch F; Parizi MK; Mostafaei H; Lysenko I; Kimura S; Enikeev DV; Egawa S; Shariat SF
J Urol; 2020 Jun; 203(6):1075-1084. PubMed ID: 31479406
[TBL] [Abstract][Full Text] [Related]
11. Association of perioperative blood transfusion with oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
Rieken M; Schubert T; Xylinas E; Kluth L; Rouprêt M; Trinh QD; Lee RK; Al Hussein Al Awamlh B; Fajkovic H; Novara G; Margulis V; Lotan Y; Martinez-Salamanca JI; Matsumoto K; Seitz C; Remzi M; Karakiewicz PI; Scherr DS; Briganti A; Bachmann A; Shariat SF;
Eur J Surg Oncol; 2014 Dec; 40(12):1693-9. PubMed ID: 24780094
[TBL] [Abstract][Full Text] [Related]
12. PTP4A3 Independently Predicts Metastasis and Survival in Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy.
Yeh HC; Li CC; Huang CN; Hour TC; Yeh BW; Li WM; Liang PI; Chang LL; Li CF; Wu WJ
J Urol; 2015 Nov; 194(5):1449-55. PubMed ID: 26070892
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of oncologic outcomes of partial ureterectomy vs radical nephroureterectomy in upper tract urothelial carcinoma.
Bagrodia A; Kuehhas FE; Gayed BA; Wood CG; Raman JD; Kapur P; Derweesh IH; Bensalah K; Sagalowsky AI; Shariat SF; Lotan Y; Margulis V
Urology; 2013 May; 81(5):972-7. PubMed ID: 23523292
[TBL] [Abstract][Full Text] [Related]
14. Role of lymph node dissection during radical nephroureterectomy for upper urinary tract urothelial cancer: multi-institutional large retrospective study JCOG1110A.
Inokuchi J; Kuroiwa K; Kakehi Y; Sugimoto M; Tanigawa T; Fujimoto H; Gotoh M; Masumori N; Ogawa O; Eto M; Ohyama C; Yamaguchi A; Matsuyama H; Ichikawa T; Asano T; Mizusawa J; Eba J; Naito S
World J Urol; 2017 Nov; 35(11):1737-1744. PubMed ID: 28508102
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor-1 receptor expression in upper tract urothelial carcinoma.
Eich ML; Tregnago AC; Faraj SF; Palsgrove DN; Fujita K; Bezerra SM; Munari E; Sharma R; Chaux A; Netto GJ
Virchows Arch; 2019 Jan; 474(1):21-27. PubMed ID: 30338346
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of BAP1 expression in high-grade upper tract urothelial carcinoma: a multi-institutional study.
Aydin AM; Singla N; Panwar V; Woldu SL; Freifeld Y; Wood CG; Karam JA; Weizer AZ; Raman JD; Remzi M; Rioux-Leclercq N; Haitel A; Roscigno M; Bolenz C; Bensalah K; Westerman ME; Sagalowsky AI; Shariat SF; Lotan Y; Bagrodia A; Kapur P; Margulis V; Krabbe LM
World J Urol; 2019 Nov; 37(11):2419-2427. PubMed ID: 30759271
[TBL] [Abstract][Full Text] [Related]
17. Pretreatment serum pseudocholinesterase level as a novel prognostic biomarker for upper tract urothelial carcinoma.
Zhang B; Shen C; Jin J; Song Y; Zhao Z; Zhang X; Wang G; Fan Y; Mi Y; Hu S; Cui Y; Zhou L; He Z; Yu W; Han W
Int Urol Nephrol; 2016 Dec; 48(12):1993-1999. PubMed ID: 27554671
[TBL] [Abstract][Full Text] [Related]
18. Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy.
Yafi FA; Novara G; Shariat SF; Gupta A; Matsumoto K; Walton TJ; Fritsche HM; El-Hakim A; Trischler S; Martínez-Salamanca JI; Seitz C; Ficarra V; Zattoni F; Karakiewicz PI; Kassouf W
BJU Int; 2012 Jul; 110(2 Pt 2):E7-13. PubMed ID: 22177329
[TBL] [Abstract][Full Text] [Related]
19. Laparoscopic radical nephroureterectomy is associated with worse survival outcomes than open radical nephroureterectomy in patients with locally advanced upper tract urothelial carcinoma.
Kim HS; Ku JH; Jeong CW; Kwak C; Kim HH
World J Urol; 2016 Jun; 34(6):859-69. PubMed ID: 26497823
[TBL] [Abstract][Full Text] [Related]
20. Impact of preoperative anemia on oncologic outcomes of upper tract urothelial carcinoma treated with radical nephroureterectomy.
Rink M; Sharifi N; Fritsche HM; Aziz A; Miller F; Kluth LA; Ngamsri T; Dahlem R; Chun FK; Shariat SF; Stenzl A; Fisch M; Gakis G
J Urol; 2014 Feb; 191(2):316-22. PubMed ID: 24036235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
